📊 DLB Key Takeaways
Is DLB a Good Investment? Thesis Analysis
Dolby Laboratories demonstrates exceptional financial health with industry-leading profitability margins (87.5% gross, 17.9% operating) and strong liquidity (3.17x current ratio). The company generates substantial free cash flow ($50.2M) with minimal leverage, supported by a fortress balance sheet with $643.8M cash and zero long-term debt.
Why Buy DLB? Key Strengths
- Exceptional gross margin of 87.5% indicating strong pricing power and operational efficiency
- Fortress balance sheet with $643.8M cash, zero long-term debt, and 0.00x debt-to-equity ratio
- Strong free cash flow generation of $50.2M (14.5% FCF margin) with minimal capex requirements
- Excellent liquidity metrics (3.17x current ratio, 3.10x quick ratio) providing substantial financial flexibility
- High interest coverage ratio of 386.1x reflecting minimal financial risk
- Substantial insider activity with 13 Form 4 filings in last 90 days
DLB Investment Risks to Consider
- Revenue spike of 8674.3% YoY appears anomalous and warrants investigation into one-time items or accounting changes affecting comparability
- Low returns on equity (2.1%) and assets (1.7%) despite strong margins suggest significant underutilized capital or asset base inefficiency
- Net income essentially flat YoY (-0.6%) despite massive revenue growth indicates margin compression or significant non-operating headwinds
- Diluted EPS declined 2.6% YoY despite revenue growth, suggesting share dilution or operating deleverage
- Patent licensing business model may face regulatory or competitive pressures affecting revenue sustainability
Key Metrics to Watch
- Operating cash flow sustainability and working capital trends to validate revenue growth quality
- Gross margin trends to confirm whether the 87.5% margin is sustainable or inflated by one-time items
- Return on equity and asset efficiency metrics to understand capital deployment effectiveness
- Revenue composition and licensing revenue recognition patterns given the unusual YoY growth
DLB Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 3.17x current ratio provides a solid financial cushion.
DLB Profitability Ratios
DLB vs Default Sector
How Dolby Laboratories, Inc. compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is DLB Overvalued or Undervalued?
Based on fundamental analysis, Dolby Laboratories, Inc. has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
DLB Balance Sheet & Liquidity
DLB 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Dolby Laboratories, Inc.'s revenue has shown modest growth of 5% over the 5-year period. The most recent EPS of $2.05 reflects profitable operations.
DLB Growth Metrics (YoY)
DLB Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $346.7M | $53.3M | $0.55 |
| Q3 2025 | $288.8M | $38.4M | $0.40 |
| Q2 2025 | $364.5M | $91.8M | $0.94 |
| Q1 2025 | $315.6M | $67.0M | $0.69 |
| Q3 2024 | $288.8M | $16.4M | $0.17 |
| Q2 2024 | $364.5M | $95.7M | $0.98 |
| Q1 2024 | $315.6M | $67.0M | $0.69 |
| Q3 2023 | $289.6M | $16.4M | $0.17 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
DLB Capital Allocation
DLB SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Dolby Laboratories, Inc. (CIK: 0001308547)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DLB
What is the AI rating for DLB?
Dolby Laboratories, Inc. (DLB) has an AI rating of STRONG BUY with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are DLB's key strengths?
Claude: Exceptional gross margin of 87.5% indicating strong pricing power and operational efficiency. Fortress balance sheet with $643.8M cash, zero long-term debt, and 0.00x debt-to-equity ratio.
What are the risks of investing in DLB?
Claude: Revenue spike of 8674.3% YoY appears anomalous and warrants investigation into one-time items or accounting changes affecting comparability. Low returns on equity (2.1%) and assets (1.7%) despite strong margins suggest significant underutilized capital or asset base inefficiency.
What is DLB's revenue and growth?
Dolby Laboratories, Inc. reported revenue of $346.7M.
Does DLB pay dividends?
Dolby Laboratories, Inc. pays dividends, with $34.3M distributed to shareholders in the trailing twelve months.
Where can I find DLB SEC filings?
Official SEC filings for Dolby Laboratories, Inc. (CIK: 0001308547) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DLB's EPS?
Dolby Laboratories, Inc. has a diluted EPS of $0.55.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DLB a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, Dolby Laboratories, Inc. has a STRONG BUY rating with 85% confidence. The AI analysis suggests favorable fundamentals based on SEC filings. This is not investment advice.
Is DLB stock overvalued or undervalued?
Valuation metrics for DLB: ROE of 2.1% (sector avg: 15%), net margin of 15.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy DLB stock in 2026?
Our dual AI analysis gives Dolby Laboratories, Inc. a combined STRONG BUY rating for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is DLB's free cash flow?
Dolby Laboratories, Inc.'s operating cash flow is $54.8M, with capital expenditures of $4.6M. FCF margin is 14.5%.
How does DLB compare to other Default stocks?
Vs Default sector averages: Net margin 15.4% (avg: 12%), ROE 2.1% (avg: 15%), current ratio 3.17 (avg: 1.8).